SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Juran S) "

Sökning: WFRF:(Juran S)

  • Resultat 11-20 av 29
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  •  
17.
  • Weismuller, T. J., et al. (författare)
  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
  • 2017
  • Ingår i: Gastroenterology. - : Elsevier BV. - 0016-5085 .- 1528-0012. ; 152:8
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical phenotypes in a large international cohort of patients with PSC. METHODS: We performed a retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centers in Europe, North America, and Australia. For each patient, we collected data on sex, clinician-reported age at and date of PSC and IBD diagnoses, phenotypes of IBD and PSC, and date and indication of IBD-related surgeries. The primary and secondary endpoints were liver transplantation or death (LTD) and hepatopancreatobiliary malignancy, respectively. Cox proportional hazards models were applied to determine the effects of individual covariates on rates of clinical events, with time-to-event analysis ascertained through Kaplan-Meier estimates. RESULTS: Of the 7121 patients in the cohort, 2616 met the primary endpoint (median time to event of 14.5 years) and 721 developed hepatopancreatobiliary malignancy. The most common malignancy was cholangiocarcinoma (n = 594); patients of advanced age at diagnosis had an increased incidence compared with younger patients (incidence rate: 1.2 per 100 patient-years for patients younger than 20 years old, 6.0 per 100 patient-years for patients 21-30 years old, 9.0 per 100 patient-years for patients 31-40 years old, 14.0 per 100 patient-years for patients 4150 years old, 15.2 per 100 patient-years for patients 51-60 years old, and 21.0 per 100 patient-years for patients older than 60 years). Of all patients with PSC studied, 65.5% were men, 89.8% had classical or large-duct disease, and 70.0% developed IBD at some point. Assessing the development of IBD as a time-dependent covariate, Crohn's disease and no IBD (both vs ulcerative colitis) were associated with a lower risk of LTD (unadjusted hazard ratio [HR], 0.62; P <.001 and HR, 0.90; P =.03, respectively) and malignancy (HR, 0.68; P =.008 and HR, 0.77; P =.004, respectively). Small-duct PSC was associated with a lower risk of LTD or malignancy compared with classic PSC (HR, 0.30 and HR, 0.15, respectively; both P <.001). Female sex was also associated with a lower risk of LTD or malignancy (HR, 0.88; P =.002 and HR, 0.68; P <.001, respectively). In multivariable analyses assessing the primary endpoint, small-duct PSC characterized a low-risk phenotype in both sexes (adjusted HR for men, 0.23; P <.001 and adjusted HR for women, 0.48; P =.003). Conversely, patients with ulcerative colitis had an increased risk of liver disease progression compared with patients with Crohn's disease (HR, 1.56; P <.001) or no IBD (HR, 1.15; P =.002). CONCLUSIONS: In an analysis of data from individual patients with PSC worldwide, we found significant variation in clinical course associated with age at diagnosis, sex, and ductal and IBD subtypes. The survival estimates provided might be used to estimate risk levels for patients with PSC and select patients for clinical trials.
  •  
18.
  •  
19.
  • Juran, SA, et al. (författare)
  • Electrophysiological Correlates of Impaired Response Inhibition During Inhalation of Propionic Acid
  • 2013
  • Ingår i: JOURNAL OF PSYCHOPHYSIOLOGY. - : Hogrefe Publishing Group. - 0269-8803 .- 2151-2124. ; 27:3, s. 131-141
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Chemosensory stimulation can impair cognitive processing, which we demonstrated previously in human volunteers who showed reduced behavioral accuracy in a go/nogo flanker task during 4-hr, whole-body exposure to 10 ppm propionic acid but not during 0.3 or 5 ppm exposures ( Hey et al., 2009 ). Now we investigated event-related potentials (ERP) in a subgroup of six male volunteers from the same study to identify which cognitive processes were sensitive to propionic acid exposure. The ERP subgroup showed the same increases in chemosensory perceptions and error rate during 10 ppm exposure as the whole group. In addition several exposure-related effects were seen in the ERPs: first there were effects of the absolute level of exposure on ERP components related to inhibition (nogo-P3) and conscious error perception (late PE). We assume that the unpleasant smell of propionic acid mediates these effects. Second, there were effects related to the variability of exposure on components related to processing in conflict and error trials (N2 and error-P3). We assume that exposure variability disturbs processing especially in critical task situations such as conflict and errors. From our results we conclude that ERPs are a valuable tool to examine chemosensory mediated impairment on different cognitive processing states and their neural substrates.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 29

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy